Key facts
- It has raised $11.5M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Suzhou Oriza Holdings Corporation, Addor Capital, Qiming Venture Partners, China Merchants Capital, DPH Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Inscinstech
- ·The full record, as it builds
Funding rounds
No funding rounds for Inscinstech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inscinstech
Developer of biological separation technology for biopharmaceutical CMCs. The company aims to develop environmental monitoring devices and equipment used in bio labs, providing clients with quick chemical analysis and high quality data while reducing lab costs.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2017
- Website
- inscinstech.com.cn/
- Ownership
- Privately Held (backing)
Inscinstech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inscinstech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inscinstech in its N-PORT filings yet. We sweep new filings monthly.